Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)
Ginkgo Bioworks Holdings posted quarterly Interest Expenses of $31.4 million for Q4 2024, down 28.72% year-on-year from $44.0 million in Q1 2024, and up 439.09% on a QoQ basis from -$9.3 million in Q3 2024.
Ginkgo Bioworks Holdings (DNA) has 4 years of Interest Expenses data on file, last reported at $31.4 million in Q4 2024.
- For the quarter ending Q4 2024, Interest Expenses fell 28.72% year-over-year to $31.4 million; the trailing twelve-month figure through Sep 2025 stood at $31.4 million (up 28.34% YoY), and the FY2024 full-year result was $94000.0, up 1.08% from the prior year.
- Interest Expenses for Q4 2024 stood at $31.4 million, up from -$9.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $44.0 million in Q4 2023 and bottomed at -$15.0 million in Q3 2023.
- The 4-year median for Interest Expenses is $570500.0 (2020), against an average of $2.9 million.
- Peak annual rise in Interest Expenses reached 38.41% in 2024, while the deepest fall reached 28.72% in 2024.
- A 4-year view of Interest Expenses shows it stood at $590000.0 in 2020, then fell by 6.61% to $551000.0 in 2021, then soared by 7886.75% to $44.0 million in 2023, then slipped by 28.72% to $31.4 million in 2024.
- The last three Interest Expenses figures came in at $31.4 million (Q4 2024), -$9.3 million (Q3 2024), and -$10.3 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 31.37 Mn |
| Dec 31, 2024 | 31.37 Mn |
| Sep 30, 2024 | -9.25 Mn |
| Sep 30, 2024 | -9.25 Mn |
| Jun 30, 2024 | -10.31 Mn |
| Jun 30, 2024 | -10.31 Mn |
| Dec 31, 2023 | 44.01 Mn |
| Dec 31, 2023 | 44.01 Mn |
| Sep 30, 2023 | -15.02 Mn |
| Sep 30, 2023 | -15.02 Mn |
| Jun 30, 2023 | -14.35 Mn |
| Jun 30, 2023 | -14.35 Mn |
| Dec 31, 2021 | 551,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Sep 30, 2020 | 592,000.00 |